RAY1225

Main study objectives: To evaluate the pharmacokinetic differences of RAY1225 injection in subjects with mild, moderate or severe renal impairment and normal renal function, and to provide a basis for the formulation of clinical medication regimens for patients with renal impairment. Secondary study objectives: To evaluate the safety and tolerability of RAY1225 injection after a single injection in subjects with mild, moderate or severe renal impairment and normal renal function.